Sarepta Therapeutics Inc.

0L35•London Stock Exchange

United Kingdom

Need professional-grade analysis? Visit stockanalysis.com

£16.70

+0.91%

End of day

Market Cap

N/A

P/E Ratio

N/A

Employees

N/A

Dividend Yield

N/A

Price Chart

Risk-Adjusted Performance

Ratio	1W	1M	3M	6M	1Y	5Y	Score
Sortino	—	-1.17	—	—	—	—	-1.17
Calmar	—	-3.63	—	—	—	—	-3.63
Sharpe	—	-0.84	—	—	—	—	-0.84
Omega	—	0.74	—	—	—	—	0.74
Martin	—	-6.39	—	—	—	—	-6.39
Ulcer	—	9.59	—	—	—	—	9.59

Also Listed On

S1RP34.SA

SA · BRL

$9.24B

SRPT.US

United States · USD

Sarepta Therapeutics Inc. (0L35) Price Performance

Sarepta Therapeutics Inc. (0L35) trades on London Stock Exchange in GBP. The stock currently trades at GBP16.70, up 0.91% from the previous close.

Over the past year, 0L35 has traded between a low of GBP15.89 and a high of GBP20.93. The stock has lost 20.2% over this period. It is currently 20.2% below its 52-week high.

Company Info

Sector: N/A
Industry: N/A
Exchange: London Stock Exchange
Currency: GBP
Country: United Kingdom

Financial Metrics

Revenue (TTM): N/A
EBITDA: N/A
Profit Margin: N/A
EPS (TTM): N/A
Book Value: N/A

Technical Indicators

52 Week High: £21.05
52 Week Low: £15.56
50 Day MA: N/A
200 Day MA: N/A
Beta: N/A

Valuation

Trailing P/E: N/A
Forward P/E: N/A
Price/Sales: N/A
Price/Book: N/A
Enterprise Value: N/A